Idorsia is reaching out for more - We have more ideas, we see more opportunities and we want to help more patients.
In order to achieve this we will develop Idorsia into one of Europe’s leading biopharmaceutical companies, with a strong scientific core.
Headquartered in Switzerland - a European biotech hub - Idorsia is specialized in the discovery and development of small molecules, to transform the horizon of therapeutic options. Idorsia has a broad portfolio of innovative drugs in the pipeline, an experienced team, a fully-functional research center, and a strong balance sheet – the ideal constellation to bringing R&D efforts to business success.
Idorsia was listed on the SIX Swiss Exchange (ticker symbol: IDIA) in June 2017 and has over 1200 highly qualified specialists dedicated to realizing our ambitious targets.
Informations clés
- Chimie / Pharma
- 1200 employés
- Hegenheimermattweg 91, Allschwil
- Idorsia Pharmaceuticals Ltd
De nouveaux emplois directement dans votre mailbox?
Il n'y a actuellement aucune offre d'emploi. Suivez cette entreprise et nous vous informerons dès que de nouveaux emplois seront disponibles.